tiprankstipranks
Trending News
More News >
Apimeds Pharmaceuticals US, Inc. (APUS)
:APUS
US Market

Apimeds Pharmaceuticals US, Inc. (APUS) Market Cap & Net Worth

Compare
17 Followers

Apimeds Pharmaceuticals US, Inc. Market Cap

Apimeds Pharmaceuticals US, Inc. has a market cap or net worth of $24.52M as of Mar 24, 2026. Its market cap has decrease by Infinity% in one year.
Market Cap
$24.52M
Enterprise Value
$18.04M
1-Year Change
Infinity%
Category
Micro (Under 300M)
Stock Price
$1.95

Market Cap Chart

Market Cap History
Date
Market Cap
% Change
Mar 23, 2026
24.52M-5.34%
Mar 20, 2026
25.91M+5.64%
Mar 19, 2026
24.52M+14.04%
Mar 18, 2026
21.50M+3.01%
Mar 17, 2026
20.88M+1.22%
Mar 16, 2026
20.62M+1.23%
Mar 13, 2026
20.37M+14.89%
Mar 12, 2026
17.73M+5.22%
Mar 11, 2026
16.85M-0.74%
Mar 10, 2026
16.98M+3.85%